TABLE 2.
Variable | Cases (N = 31) | Controls (N = 104) | P Value |
---|---|---|---|
Age, years | 54 ± 10 | 52 ± 10 | 0.41 |
Female sex | 20 (65%) | 40 (39%) | 0.01 |
Race | 0.37 | ||
White | 29 (94%) | 92 (88%) | |
Black | 0 | 7 (7%) | |
Other | 2 (6%) | 5 (5%) | |
Etiology of portal hypertension | |||
Alcohol | 14 (45%) | 45 (43%) | 0.85 |
Hepatitis C | 6 (19%) | 51 (49%) | 0.003 |
Autoimmune hepatitis | 7 (23%) | 4 (4%) | 0.003 |
Nonalcoholic fatty liver disease | 1 (3%) | 8 (75%) | 0.68 |
Hepatitis B | 1 (3%) | 6 (6%) | 1.0 |
Primary sclerosing cholangitis | 1 (3%) | 9 (9%) | 0.45 |
Primary biliary cirrhosis | 3 (10%) | 3 (3%) | 0.13 |
Cryptogenic | 2 (6%) | 8 (8%) | 1.0 |
Model for End-stage Liver Disease score | 12 ± 4 (N = 29) | 12 ± 5 (N = 103) | 0.77 |